FASLG and age-related macular degeneration: Our results strongly suggest that 6R-FBP effectively blocks the Fas/FasL interaction, leading to the inhibition of apoptosis and inflammation, thereby positioning 6R-FBP as a promising inhibitor of AMD progression.